The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2020Assessing Target Engagement for Terazosin
Study Rationale:
Patients with Parkinson’s disease (PD) do not produce enough of a compound called ATP. If a person does not make enough ATP, the cells in the body can die. This is very important... -
Research Grant, 2020Safety and Tolerability of NLX-112 in People with Parkinson’s
Study Rationale:
Motor symptoms of Parkinson’s disease are caused by a lack of brain neurons that carry a neurotransmitter called dopamine, and are commonly treated with levodopa. However, after... -
Biosample Use Program, 2020Mass Spectrometric Analysis of Glucocerebrosidase Protein Levels and Spinal Fluid in People with Parkinson’s
Study Rationale:
Mutations in the glucocerebrosidase (GBA) gene are among the most important risk factors for developing Parkinson´s disease. GBA activity is reduced in cerebrospinal fluid (CSF) of... -
Biosample Use Program, 2020Identification of Autoantibodies in People at Risk of Developing Parkinson’s Disease Using Microarrays
Study Rationale:
Autoantibodies are antibodies that mistakenly target and react with a person's own tissues or organs. Autoantibodies can be detected many years before symptoms develop in many... -
Aligning Science Across Parkinson's, 2020In Vivo Approach to Elucidate the Pathobiology of Parkinson’s-associated Genes Using Human Diseased Neurons
Study Rationale:
Several genes are known to be associated with Parkinson’s disease, although how they impact the disease process is not fully understood. Here we will use stem cells from patients in... -
Aligning Science Across Parkinson's, 2020Senescence in Parkinson’s Disease and Related Disorders
Study Rationale:
While aging is the greatest risk factor for development of Parkinson’s disease (PD), how aging promotes PD is not fully understood. Examining the role of cellular senescence...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.